Emtricitabine

Emtricitabine is a synthetic analogue nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the ability of HIV to multiply within your body.

It is one of the most powerful nucleoside analogue reverse transcriptase inhibitors. The most common symptom of HIV infection is the failure of the body's immune system to fight the virus. This leads to a progressive infection of the body. Emtricitabine prevents HIV from changing the DNA of healthy cells.

It penetrates the cells and the nucleus and inhibits the replication of the HIV-1 virus in the body. Emtricitabine is a key component in several HIV medicines used to treat HIV infection. It is a nucleotide analogue inhibitor of HIV-1 reverse transcriptase with a highly selective affinity for HIV-1 reverse transcriptase.

Emtricitabine is one of the drugs used in the treatment of HIV infection. It is a prescription drug and requires a doctor's note before it can be prescribed.

It is mainly used to treat HIV, Hepatitis B infection, Herpes Simplex Virus Type 1 infection. It treats HIV infection in adults and children who are at least three months old.

It is used with other antiretroviral agents, such as tenofovir, to increase the effectiveness of reducing the risk of HIV disease progression.

In combination with tenofovir disoproxil, fumarate Emtricitabine is indicated in treating patients with HIV-1 infections who have been previously treated with other antiretroviral therapy.